Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
1.010
-0.010 (-0.98%)
Dec 20, 2024, 4:00 PM EST - Market closed
Cue Biopharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 64 | 119 | 123 | 359 | 379 | 365 | |
| Market Cap Growth | -55.91% | -2.89% | -65.85% | -5.17% | 3.77% | 285.76% | |
| Enterprise Value | 41 | 81 | 83 | 295 | 295 | 341 | |
| Last Close Price | 1.01 | 2.64 | 2.85 | 11.31 | 12.51 | 15.88 | |
| PS Ratio | 5.25 | 21.70 | 98.53 | 24.04 | 120.08 | 105.55 | |
| PB Ratio | 2.40 | 3.21 | 1.87 | 5.48 | 4.80 | 6.69 | |
| P/TBV Ratio | 1.80 | 3.21 | 1.87 | 5.48 | 4.80 | 6.69 | |
| EV/Sales Ratio | 4.31 | 14.72 | 66.75 | 19.76 | 93.58 | 98.51 | |
| Debt / Equity Ratio | 0.37 | 0.40 | 0.29 | 0.15 | 0.09 | 0.11 | |
| Asset Turnover | 0.17 | 0.07 | 0.01 | 0.16 | 0.04 | 0.06 | |
| Quick Ratio | 2.12 | 2.94 | 6.61 | 5.28 | 5.29 | 5.16 | |
| Current Ratio | 2.22 | 3.01 | 6.68 | 5.35 | 5.36 | 5.24 | |
| Return on Equity (ROE) | -131.15% | -98.73% | -80.82% | -61.16% | -67.10% | -82.88% | |
| Return on Assets (ROA) | -50.18% | -42.53% | -38.28% | -29.87% | -32.90% | -39.29% | |
| Return on Capital (ROIC) | -60.74% | -47.51% | -41.66% | -33.81% | -38.45% | -48.71% | |
| Earnings Yield | -69.72% | -42.59% | -43.21% | -12.29% | -11.82% | -10.05% | |
| FCF Yield | -59.89% | -33.55% | -34.22% | -11.07% | -8.74% | -8.45% | |
| Buyback Yield / Dilution | -13.18% | -28.35% | -13.95% | -9.05% | -30.16% | -9.48% | |
| Total Shareholder Return | -13.18% | -28.35% | -13.95% | -9.05% | -30.16% | -9.48% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.